The DNA of four former presidents is set to be blasted off into the cosmos as the ultimate memorial.

Celestis, a leading company in space burials, is taking the helm on the project to honor George Washington, Dwight D. Eisenhower, John F. Kennedy, and Ronald Reagan sending their genetic information to space aboard its Enterprise Flight.

Some of pop culture's favorite space travelers from Star Trek are also to be honored: Gene Roddenberry, Majel Barrett Rodenberry, Nichelle Nichols, and more. The 2001: A Space Odyssey VFX master Douglas Trumbull's remains will also be making the trip.

"Beyond establishing the first human outpost in deep space, the answers are rooted in possible discovery and off-world genetic and data storage," the company wrote in a blog post.

The rocket is expected to carry the collected DNA to deep space — about 93 million miles to 186 million miles away from Earth, and the company said part of their goal for the launch of the remains is to expand the presence of humanity throughout the cosmos. 

"The overarching goal of Celestis is to assist human expansion throughout the solar system. By adding the DNA of these American icons to Enterprise, we establish a precursor for future human missions, and add to the historical record of human exploration of deep space," said Charles M. Chafer, co-founder and CEO of Celestis.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More